EUVIMEDEUVIMED entdecken
Crossref

Asprosin attenuates diabetic cardiomyopathy through inhibiting autophagy mediated by AMPK/mTOR/ULK1 pathway

Yuan Wang, Wentao Liu, Chen Liu, Zhitong Zhou, Sheng Chen, Qianqian Huang, Li Wang, Guohua Zeng, Qiren Huang iD

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.01006.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Yuan Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of Chi…. Hauptthemen laut MEDLINE: Autophagy, Autophagy-Related Protein-1 Homolog, TOR Serine-Threonine Kinases, Diabetic Cardiomyopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Jiangxi Provincial Department of Science and Technology (), Health Commission of Jiangxi Province ().

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We demonstrated for the first time that asprosin (ASP) has protective effects against diabetic cardiomyopathy. We found that ASP could stimulate the AMPK/mTOR/ULK1 pathway to reduce the level of autophagy and apoptosis of cardiomyocytes, thereby maintaining the normal physiological function of the heart.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyAutophagy-Related Protein-1 HomologTOR Serine-Threonine KinasesDiabetic CardiomyopathiesAMP-Activated Protein KinasesDiabetes Mellitus, ExperimentalAnimalsMiceMaleMyocytes, CardiacSignal TransductionMice, Inbred C57BLApoptosisRatsCell LineMice, Knockout

Stichwörter der Autor:innen

apoptosisasprosinautophagydiabetic cardiomyopathyfibrosis

Substanzen

Autophagy-Related Protein-1 HomologTOR Serine-Threonine KinasesAMP-Activated Protein KinasesUlk1 protein, mousemTOR protein, mouse

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
  • Jiangxi Provincial Key Laboratory of Drug Target Discovery and Validation, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.

ORCID-Profile: Qiren Huang

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Jiangxi Provincial Department of Science and Technology ()
  • Health Commission of Jiangxi Province ()
  • Nanchang University (NCU)

Zitieren

APA

Wang, Y., Liu, W., Liu, C., Zhou, Z., Chen, S., Huang, Q., Wang, L., Zeng, G., & Huang, Q. (2025). Asprosin attenuates diabetic cardiomyopathy through inhibiting autophagy mediated by AMPK/mTOR/ULK1 pathway. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.01006.2024

Vancouver

Wang Y, Liu W, Liu C, Zhou Z, Chen S, Huang Q, et al. Asprosin attenuates diabetic cardiomyopathy through inhibiting autophagy mediated by AMPK/mTOR/ULK1 pathway. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.01006.2024

BibTeX
@article{Wang2025,
  author = {Wang, Yuan and Liu, Wentao and Liu, Chen and Zhou, Zhitong and Chen, Sheng and Huang, Qianqian and Wang, Li and Zeng, Guohua and Huang, Qiren},
  title = {Asprosin attenuates diabetic cardiomyopathy through inhibiting autophagy mediated by AMPK/mTOR/ULK1 pathway},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.01006.2024}
}
Kostenlos starten →